Mamoli B, Wessely P, Kogelnik H D, Müller M, Rathkolb O
Eur Neurol. 1979;18(6):405-14. doi: 10.1159/000115113.
13 patients with malignant tumors were treated by the radiosensitizer misonidazole (Ro 07-0582), total dosage 20-29 g. The electrophysiological investigations showed (1) an early increase of distal latency, the motor nerve conduction velocity (NCV) of the peroneal nerve and the NCV of the sural nerve remaining normal or only signlty reduced, and in a few cases a marked reduction of the compound action potential or of the nerve action potential (NAP), indicating a primary axonal neuropathy; (2) greater changes in the parameters of sensory nerves (n. suralis) than of motor nerves; (3) the distal latency is a good indicator of subclinical neuropathies; (4) the electrophysiological parameters showed a normalization 6 months after the end of therapy. The mechanisms possibly responsible for the misonidazole neuropathy are discussed.
13例恶性肿瘤患者接受放射增敏剂米索硝唑(Ro 07 - 0582)治疗,总剂量为20 - 29克。电生理研究显示:(1)远端潜伏期早期增加,腓总神经运动神经传导速度(NCV)和腓肠神经NCV保持正常或仅略有降低,少数病例复合动作电位或神经动作电位(NAP)明显降低,提示原发性轴索性神经病;(2)感觉神经(腓肠神经)参数的变化大于运动神经;(3)远端潜伏期是亚临床神经病变的良好指标;(4)治疗结束6个月后电生理参数显示恢复正常。文中讨论了米索硝唑神经病变可能的机制。